Literature DB >> 10476819

Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.

G A Limb1, J Hickman-Casey, R D Hollifield, A H Chignell.   

Abstract

PURPOSE: To investigate whether proliferative vitreoretinopathy (PDR) is associated with a selective increase in vitreous levels of soluble vascular cell adhesion molecules that mediate leukocyte extravasation and interaction with endothelium during processes of inflammation and neovascularization.
METHODS: Vitreous from 55 patients undergoing vitrectomy for treatment of PDR complicated by vitreous hemorrhage and/or traction retinal detachment was assayed for the presence of the soluble vascular cell adhesion molecules sICAM-1, sVCAM-1, and sE-selectin using a standard enzyme-linked immunosorbent assays (ELISA). Vitreous from 12 cadaveric eyes matching age and sex of the patients were used as control samples.
RESULTS: Vitreous levels of sICAM-1, sVCAM-1, and sE-selectin were significantly higher in eyes with PDR than in control cadaveric vitreous, and levels of all three molecules did not relate to the type or duration of diabetes mellitus. However, eyes with either traction retinal detachment alone or both traction retinal detachment and vitreous hemorrhage exhibited significantly higher levels of sICAM-1 and sE-selectin than eyes with vitreous hemorrhage alone. Vitreous levels of sVCAM-1 were similar in eyes with either vitreous hemorrhage or traction retinal detachment alone.
CONCLUSIONS: The present observations suggest that molecular inflammatory mechanisms may contribute to processes of neovascularization and fibrosis observed in PDR, possibly not as the causative event, but as a result of endothelial, Müller, and retinal pigment epithelial cell activation. The results also indicate that retinal detachment amplifies the existing inflammation within the diabetic retina. Identification of any abnormalities in the production and control of specific adhesion molecules could have important implications in the design of new therapeutic regimens to treat and prevent this sight-threatening complication of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476819

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

3.  Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Gérard Lizard; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2007-12-30       Impact factor: 2.611

4.  Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients.

Authors:  Lidia Kria; Taoufik Khalfaoui; Ghada Mkannez; Omar Beltaief; Raja Anane; Khalil Errais; Lilia Tounsi; Raja Zhioua; Sarra Ben Jilani; Amel Meddeb Ouertani
Journal:  J Mol Histol       Date:  2006-02-16       Impact factor: 2.611

5.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

6.  Plasma E-selectin levels can play a role in the development of diabetic retinopathy.

Authors:  Márta Kasza; J Meleg; J Vardai; B Nagy; E Szalai; J Damjanovich; A Csutak; B Ujhelyi; V Nagy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

7.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

8.  Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy.

Authors:  Dean F Loporchio; Emily K Tam; Jane Cho; Jaeyoon Chung; Gyungah R Jun; Weiming Xia; Marissa G Fiorello; Nicole H Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

Review 9.  Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.

Authors:  Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

Review 10.  Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy.

Authors:  Daniel Gologorsky; Aristomenis Thanos; Demetrios Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.